Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo

Cancer Investigation

Volumn 30, Issue 5, 2012, Pages 380-389

  Tang, Jingqun ^a   Zhang, Liyang ^b   She, Xiaoling ^b   Zhou, Guangqian ^c   Yu, Fenglei ^a   Xiang, Juanjuan ^b   Li, Gang ^d,e  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c Shenzhen University School of Medicine   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CD164; Colon cancer; CXCR4; Metastasis

Indexed keywords

CD164 ANTIGEN; CHEMOKINE RECEPTOR CXCR4;

ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CELL PROLIFERATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN HCT116; COLON; COLON CANCER; COLORECTAL CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; OVARY CANCER; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD164; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; COLONIC NEOPLASMS; FEMALE; HCT116 CELLS; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; RECEPTORS, CXCR4;

EID: 84861041373     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2012.666692     Document Type: Article

References (25)

1. ZhouGQ, ZhangY,FergusonDJ, ChenS, Rasmuson-LestanderA, Campbell FC,Watt SM. The Drosophila ortholog of the endolysosomal membrane protein, endolyn, regulates cell proliferation. J Cell Biochem 2006;99:380-1396.
2. ZannettinoAC, BuhringHJ, Niutta S,Watt SM, BentonMA, Simmons PJ.The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis. Blood 1998;92:2613-2628. (Pubitemid 28469072)
3. Chan JY, Watt SM. Adhesion receptors on haematopoietic progenitor cells. Br J Haematol 2001;112:541-557. (Pubitemid 32222821)
4. Kurosawa N, Kanemitsu Y, Matsui T, Shimada K, Ishihama H, Muramatsu T. Genomic analysis of a murine cell-surface sialomucin, MGC-24/CD164. Eur J Biochem 1999;265:466-472. (Pubitemid 29466058)
5. Watt SM, Chan JY. CD164-a novel sialomucin on CD34+ cells. Leuk Lymphoma 2000;37:1-25. (Pubitemid 30142576)
6. Watt SM, Buhring HJ, Rappold I, Chan JY, Lee-Prudhoe J, Jones T, Zannettino AC, Simmons PJ, Doyonnas R, Sheer D, Butler LH. CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21. Blood 1998;92: 849-866. (Pubitemid 28355468)
7. Lee YN, Kang JS, Krauss RS. Identification of a role for the sialomucin CD164 in myogenic differentiation by signal sequence trapping in yeast. Mol Cellular Biol 2001;21:7696-7706. (Pubitemid 32988779)
8. Vaday GG, Hua SB, Peehl DM, Pauling MH, Lin YH, Zhu L, Lawrence DM, Foda HD, Zucker S. CXCR4 and CXCL12 (SDF- 1) in prostate cancer: inhibitory effects of human single chain Fv antibodies. Clin Cancer Res 2004;10:5630-5639. (Pubitemid 39100505)
9. Masuzawa Y, Miyauchi T, Hamanoue M, Ando S, Yoshida J, Takao S, Shimazu H, Adachi M, Muramatsu T. A novel core protein as well as polymorphic epithelial mucin carry peanut agglutinin binding sites in human gastric carcinoma cells: sequence analysis and examination of gene expression. J Biochem 1992;112:609-615.
10. Ihrke G, Gray SR, Luzio JP. Endolyn is a mucin-like type I membrane protein targeted to lysosomes by its cytoplasmic tail. Biochem J 2000;345 (II):287-296. (Pubitemid 30077169)
11. Havens AM, Jung Y, Sun YX, Wang J, Shah RB, Buhring HJ, Pienta KJ, Taichman RS. The role of sialomucin CD164 (MGC- 24v or endolyn) in prostate cancer metastasis. BMC Cancer 2006;6:195-201.
12. Wong PF, Abubakar S. Comparative transcriptional study of the effects of high intracellular zinc on prostate carcinoma cells. Oncol Rep 2010;23:1501-1516.
13. Coustan-Smith E, Song G, Clark C, Key L, Liu P, Mehrpooya M, Stow P, Su X, Shurtleff S, Pui CH, Downing JR, Campana D Newmarkers forminimal residual disease detection in acute lymphoblastic leukemia. Blood 2011;117(23):6267-6276.
14. Chirumbolo S. CD164 and other recently discovered activation markers as promising tools for allergy diagnosis: what's new? Clin Exp Med 2011;11(4):255-257.
15. Song C, Xiang J, Tang J, Hirst DG, Zhou J, Chan KM, Li G. Thymidine kinase gene modified bone marrow mesenchymal stem cells as vehicles for antitumor therapy. Hum Gene Ther 2011;22:439-449.
16. Yuan Z, Wong S, Borrelli A, Chung MA Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting Ecadherin/ catenin complex formation. Biochem Biophy Res Communication 2007;362:740-746. (Pubitemid 47368156)
17. Mowafi F,CagigiA,Matskova L,Chung MA.ChemokineCXCL12 enhances proliferation in pre-B-ALL via STAT5 activation. Pediatric Blood Cancer 2008;50:812-817. (Pubitemid 351354790)
18. Kollmar O, Rupertus K, Scheuer C, Junker B, Tilton B, Schilling MK, Menger MD. Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. Neoplasia 2007;9:862-870. (Pubitemid 47623426)
19. Porcile C, Bajetto A, Barbieri F, Barbero S, Bonavia R, Biglieri M, Pirani P, Florio T, Schettini G. Stromal cell-derived factor- 1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. Exp Cell Res 2005;308:241-253.
20. MullerA,Homey B, Soto H, Ge N, Catron D, BuchananME,Mc- Clanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-56. (Pubitemid 32225831)
21. Robledo MM, Bartolome RA, Longo N, Rodriguez-Frade JM, Mellado M, Longo I, van Muijen GN, Sanchez-Mateos P, Teixido J. Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem 2001;276:45098-45105.
22. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002;62:1832-1837. (Pubitemid 34408510)
23. Moskovits N, Kalinkovich A, Bar J, Lapidot T, Oren M. p53 attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. Cancer Res 2006;66:10671-10676. (Pubitemid 44876961)
24. Forde S, Tye BJ, Newey SE, Roubelakis M, Smythe J, McGuckin CP, Pettengell R, Watt SM. Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells. Blood 2007;109:1825-1833. (Pubitemid 46348176)
25. Bae GU,GaioU, Yang YJ, LeeHJ, Kang JS,Krauss RS. Regulation of myoblast motility and fusion by the CXCR4-associated sialomucin, CD164. J Biol Chem 2008;283:8301-8309.